NORTH AMERICA BONE GRAFT AND SUBSTITUTE MARKET FORECAST 2020-2028

NORTH AMERICA BONE GRAFT AND SUBSTITUTE MARKET FORECAST 2020-2028

  • February 2020 •
  • 143 pages •
  • Report ID: 5178775 •
  • Format: PDF
KEY FINDINGS
The North American market of bone graft and substitute market is anticipated to record a CAGR of 4.69% over the forecast period of 2020-2028. The growing geriatric population, technological innovations such as rhBMP, and favorable reimbursement rates are the major factors boosting the market growth in the region. The rising occurrences of orthopedic disorders, increasing preference for an active lifestyle among the US citizens, and surging health expenditure in Canada are predicted to boost the market growth of North America.

MARKET INSIGHTS
The bone graft and substitute market of North America is studied on the basis of the countries of the US and Canada.The bone graft and substitute market growth in Canada is driven by important factors like surging disposable income and the growing number of hip replacement procedures.

In Canada, as per the Organization for Economic Co-operation and Development (OECD), in the second quarter of 2017, household disposable income increased from $1,152.7 billion in the second quarter of 2016 to $1,213.8 billion in the second quarter of 2017, which is a rise of 5.3%. The increasing household spending among Canadians is expected to rise in expenditure of total knee and hip replacement surgeries resulting in augmenting the Canadian bone graft and substitute market growth.

COMPETITIVE INSIGHTS
NuVasive, Inc., Arthrex Inc., Bioventus, Allosource, Inc., Baxter International Inc., etc. are some of the renowned companies operating in the market.

Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Companies mentioned
1. ALLOSOURCE, INC.
2. ARTHREX
3. BAXTER INTERNATIONAL INC.
4. BIOVENTUS LLC
5. DEPUY SYNTHES COMPANIES
6. INTEGRA LIFESCIENCES
7. MATHYS AG
8. MEDTRONIC INC.
9. NUVASIVE INC.
10. ORTHOFIX HOLDINGS, INC.
11. SIGMAGRAFT
12. SMITH & NEPHEW PLC
13. STRYKER CORPORATION
14. XTANT MEDICAL HOLDINGS, INC.
15. ZIMMER BIOMET HOLDINGS INC.